Eric William Schneider MD
Retinal Disease
Vitreoretinal Specialist, Tennessee Retina
Join to View Full Profile
345 23rd Ave NSte 201Nashville, TN 37203
Phone+1 615-983-6000
Fax+1 615-983-6010
Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eric Schneider is an ophthalmologist in Nashville, TN. He received his medical degree from University of Michigan Medical School and has been in practice 9 years. He is experienced in general / comprehensive ophthalmology and vitreoretinal disease.
Education & Training
University of Michigan Health SystemResidency, Ophthalmology, 2009 - 2012
Corewell Health East Beaumont (Dearborn & Taylor)Internship, Transitional Year, 2008 - 2009
University of Michigan Medical SchoolClass of 2008
Certifications & Licensure
KY State Medical License 2014 - 2026
TN State Medical License 2014 - 2025
NC State Medical License 2012 - 2015
MI State Medical License 2008 - 2012
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01
Publications & Presentations
PubMed
- Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular Degeneration.Jeffrey S Heier, Yingna Liu, Nancy M Holekamp, Mohsin H Ali, Konstantin Astafurov
Journal of Vitreoretinal Diseases. 2024-12-07 - Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence Analytics.Eric W Schneider, Jeffrey S Heier, Nancy M Holekamp, Miguel A Busquets, Alan L Wagner
Ophthalmology Science. 2024-11-26 - Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1.Jessica M Girgis, Caroline R Baumal, Andre J Witkin, Lejla Vajzovic, Roger A Goldberg
Journal of Vitreoretinal Diseases. 2024-08-22
Press Mentions
Notal Vision Announces a Pivotal Study Demonstrating the Efficacy of AI in Enabling Home OCT MonitoringFebruary 3rd, 2025- Study Demonstrates Efficacy of AI in Enabling Home OCT MonitoringJanuary 30th, 2025
Anti-VEGF Targeted as Potential nAMD TreatmentNovember 8th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
